Company intelligence / Profile preview

Ardigen

Kraków, Lesser Poland Voivodeship, Polandardigen.com ↗

Ownership: Private
Employees: ~163
Development stage: Preclinical

Overview

Ardigen is an AI-driven CRO specializing in computational biology solutions to accelerate drug discovery. The company has supported over 15 drug programs with accurate predictions and completed more than 520 projects for over 100 clients—including top pharmaceutical companies—by providing advanced data analytics and machine learning tools to increase the probability of clinical success. It does not develop its own drugs but enables partners’ R&D pipelines through its proprietary platforms.

Therapeutic areas: Oncology
Modalities: Small moleculesBiologicssiRNA, miRNA, sgRNA (short RNA modalities)
Industry: Drug Discovery Services

Partnerships

OncoArendi Therapeutics S.A. (collaboration using Gene Regulation Platform)

Beyond the preview

Go deeper on Ardigen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ardigen.

Explore the full profile